NEW YORK (Reuters Health) Jun 07 –
The number of diabetics who have been counseled about and who use aspirin to lower cardiovascular risk has increased in the US in recent years, according to a report in the June issue of Diabetes Care.
However, even greater improvements are warranted, researchers point out. Dr. Sarah L. Krein, of the University of Michigan, Ann Arbor, and colleagues used data from a survey of diabetics to determine current physician practices and the use of aspirin by these individuals. In the early 1990s, only about 20% of diabetics were taking aspirin to lower their cardiovascular risk, Dr. Krein’s group reports.
The researchers used logistic regression analysis to examine the association between aspirin counseling, aspirin use, and reported coronary vascular disease (CVD) and classical CVD risk factors. Data were obtained using a random sample of about 1400 diabetes who were VA healthcare system outpatients between January and March 2000.
Seventy-one percent of the respondents were counseled about aspirin use by their physicians and 66% of the subjects were using aspirin daily.
“Individuals with known CVD were more likely to be counseled (odds ratio 4.9) and to use aspirin (odds ratio 2.1),” the team notes.
Having been counseled about aspirin therapy by a physician was the factor most strongly associated with aspirin use (p<0.001), according to the investigators.
Ninety-one percent of those who received aspirin counseling reported taking aspirin, compared with 10% of those not counseled.
e-Med Tools
קצר קולע וממוקד
e-Med סמינרים
אי-מד תחקירים
Medscape Tools
Journal Club
מרכזי מידע ושירות
Facebook
מידע למפרסם
מאגר תרופות
מאגר אנשי המקצוע
אינדקס שימושי
חדשות משה"ב
eMed HealthClub
מחקרים קליניים
השאירו תגובה
רוצה להצטרף לדיון?תרגישו חופשי לתרום!